1. Mechanisms of leukocyte-mediated tissue injury induced by interleukin-2

   • Alex B. Lentsch
   • Frederick N. Miller
   • Michael J. Edwards

   REVIEW Pages: 243 - 248

2. A tandem repeat of MUC1 core protein induces a weak in vitro immune response in human B cells

   • Eva Andersson
   • Paula Henderikx
   • Carl A. K. Borrebaeck

   ORIGINAL ARTICLE Pages: 249 - 256

3. Adoptive-transfer therapy of tumors with the tumor-specific primary cytotoxic T cells induced in vitro with the B7.1-transduced MCA205 cell line

   • Sun Jung Kim
   • Michel Sadelain
   • Hee Young Chung

   ORIGINAL ARTICLE Pages: 257 - 264

4. In vivo interleukin-2 gene therapy of established tumors with herpes simplex amplicon vectors

   • Michael D'Angelica
   • Howard Karpoff
   • Yuman Fong

   ORIGINAL ARTICLE Pages: 265 - 271

5. Isolation of MUC1-primed B lymphocytes from tumour-draining lymph nodes by immunomagnetic beads

   • Claudia Petrarca
   • Beniamino Casalino
   • Marianna Nuti

   ORIGINAL ARTICLE Pages: 272 - 277

6. Fas-ligand-mediated lysis of erbB-2-expressing tumour cells by redirected cytotoxic T lymphocytes

   • Nicole M. Haynes
   • Mark J. Smyth
   • Phillip K. Darcy

   ORIGINAL ARTICLE Pages: 278 - 286

7. Organ-specific pancreatic tumor growth properties and tumor immunity

   • Keita Morikane
   • Richard M. Tempero
   • Michael A. Hollingsworth

   ORIGINAL ARTICLE Pages: 287 - 296